Strategies for Positioning Fluorescent Probes and Crosslinkers on Formyl Peptide Ligands

References

• Drubbisch V., Lameh J., Philip M., Sharma Y. K., Sadee W. Mapping the ligand binding pocket of the human muscarinic cholinergic receptor Hm1: contribution of tyrosine-82. Pharmac. Research 1992; 9: 1644–1647
   Google Scholar
• Fong T. M., Huang R. R., Strader C. D. Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J. Biol. Chem. 1992; 267: 25664–255667
   PubMed Web of Science ®Google Scholar
• Fong T. M., Yu H., Huang R. R., Strader C. D. The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides. Biochemistry 1992; 31: 11806–11811
   PubMedGoogle Scholar
• Hibert M. F., Trumpp-Kallmeyer S., Bruinvels A., Hoflack J. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol. Pharmacol. 1991; 40: 8–15
   PubMed Web of Science ®Google Scholar
• Huang R. R., Yu H., Strader C. D., Fong T. M. Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor. Biochemistry 1994; 33: 3007–3013
   PubMedGoogle Scholar
• Huang R. R., Yu H., Strader C. D., Fong T. M. Localization of the ligand binding site of the neurokinin-1 receptor: interpretation of chimeric mutations and single-residue substitutions. Mol. Pharmacol. 1994; 45: 690–695
   Google Scholar
• Huggins J. P., Trumpp-Kallmeyer S., Hibert M. F., Hoflack J. M., Fanger B. O., Jones C. R. Modelling and modification of the binding site of endothelin and other receptors. Euro. J. Pharmac. 1993; 245: 203–214
   Google Scholar
• Li Y. M., Marnerakis M., Stimson E. R., Maggio J. E. Mapping peptide-binding domains of the substance P (NK-1) receptor from P388D1 cells with photolabile agonists. J. Biol. Chem. 1995; 270: 1213–1220
   PubMed Web of Science ®Google Scholar
• Nakayama T. A., Khorana H. G. Orientation of retinal in bovine rhodopsin determined by cross-linking using a photoactivatable analog of 11-cis-retinal. J. Biol. Chem. 1990; 265: 15762–15769
   Google Scholar
• Nakayama T. A., Khorana H. G. Mapping of the amino acids in membrane-embedded helices that interact with the retinal chromophore in bovine rhodopsin. J. Biol. Chem. 1991; 266: 4269–4275
   PubMed Web of Science ®Google Scholar
• Nordvall G., Hacksell U. Binding-site modeling of the muscarinic m1 receptor: a combination of homology-based and indirect approaches. J. Med. Chem. 1993; 36: 967–976
   PubMedGoogle Scholar
• Perlman J. H., Laakkonen L., Osman R., Gershengorn M. C. A model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Evidence for a second direct interaction between transmembrane helix 3 and TRH. J. Biol. Chem. 1994; 269: 23383–23386
   Google Scholar
• Trumpp-Kallmeyer S., Hoflack J., Bruinvels A., Hibert M. Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J. Med. Chem. 1992; 35: 3448–3462
   PubMed Web of Science ®Google Scholar
• Yamamoto Y., Kamiya K., Terao S. Modeling of human thromboxane A2 receptor and analysis of the receptor-ligand interaction. J. Med. Chem. 1993; 36: 820–825
   PubMed Web of Science ®Google Scholar
• Henderson R., Baldwin J. M., Ceska T. A., Zemlin F., Beckmann E., Downing K. H. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J. Mol. Biol. 1990; 213: 899–929
   PubMed Web of Science ®Google Scholar
• Schertler G. F., Villa C., Henderson R. Projection structure of rhodopsin. Nature 1993; 362: 770–772
   PubMed Web of Science ®Google Scholar
• Dixon R. A., Sigal I. S., Rands E., Register R. B., Candelore M. R., Blake A. D., Strader C. D. Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core. Nature 1987; 326: 73–77
   PubMedGoogle Scholar
• Zhang D., Weinstein H. Signal transduction by a 5-HT2 receptor: a mechanistic hypothesis from molecular dynamics simulations of the three-dimensional model of the receptor complexed to ligands. J. Med. Chem. 1993; 36: 934–938
   PubMed Web of Science ®Google Scholar
• Ji I., Ji T. H. Differential roles of exoloop 1 of the human follicle-stimulating hormone receptor in hormone binding and receptor activation. J. Biol. Chem. 1995; 270: 15970–15973
   Google Scholar
• Leng N., Dattatreyamurty B., Reichert L. E., Jr. Identification of amino acid residues 300–315 of the rat FSH receptor as a hormone binding domain: evidence for its interaction with specific regions of FSH beta-subunit. Biochem. Biophys. Res. Comm. 1995; 210: 392–399
   Google Scholar
• Perez H. D., Holmes R., Vilander L. R., Adams R. R., Manzana W., Jolley D., Andrews W. H. Formyl peptide receptor chimeras define domains involved in ligand binding. J. Biol. Chem. 1993; 268: 2292–2295
   PubMedGoogle Scholar
• Quehenberger O., Prossnitz E. R., Cavanagh S. L., Cochrane C. G., Ye R. D. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors. J. Biol. Chem. 1993; 268: 18167–18175
   Google Scholar
• Radel S. J., Genco R. J., De Nardin E. Localization of ligand binding regions of the human formyl peptide receptor. Biochem. Internatl. 1991; 25: 745–753
   PubMedGoogle Scholar
• Trumpp-Kallmeyer S., Chini B., Mouillac B., Barberis C., Hoflack J., Hibert M. Towards understanding the role of the first extracellular loop for the binding of peptide hormones to G-protein coupled receptors. Pharmaceutica Acta Helvetiae 1995; 70: 255–262
   Google Scholar
• Ward P. A., Lepow I. H., Newman L. J. Bacterial factors chemotactic for polymorphonuclear leukocytes. American Journal of Pathology 1968; 52: 725–736
   PubMed Web of Science ®Google Scholar
• Schiffmann E., Corcoran B. A., Wahl S. M. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc. Natl. Acad. Sci. U.S.A. 1975; 72: 1059–1062
   PubMed Web of Science ®Google Scholar
• Showell H. J., Freer R. J., Zigmond S. H., Schiffmann E., Aswanikumar S., Corcoran B., Becker E. L. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils. J. Exper. Med. 1976; 143: 1154–1169
   PubMed Web of Science ®Google Scholar
• Freer R. J., Day A. R., Radding J. A., Schiffmann E., Aswanikumar S., Showell H.J., Becker E. L. Further studies on the structural requirements for synthetic peptide chemoattractants. Biochemistry 1980; 19: 2404–2410
   PubMed Web of Science ®Google Scholar
• Toniolo C., Crisma M., Valle G., Bonora G. M., Polinelli S., Becker E. L., Freer R. J., Sudhanand, et al. Conformationally restricted formyl methionyl tripeptide chemoattractants: a three-dimensional structure-activity study of analogs incorporating a C alpha, alpha-dialkylated glycine at position 2. Peptide Research 1989; 2: 275–281
   PubMedGoogle Scholar
• Fay S. P., Domalewski M. D., Sklar L. A. Evidence for protonation in the human neutrophil formyl peptide receptor binding pocket. Biochemistry 1993; 32: 1627–1631
   PubMed Web of Science ®Google Scholar
• Zhou W., Flanagan C., Ballesteros J. A., Konvicka K., Davidson J. S., Weinstein H., Millar R. P., Sealfon S. C. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol. Pharmacol. 1994; 45: 165–170
   Google Scholar
• Kage R., Leeman S. E., Krause J. E., Costello C. E., Boyd N. D. Identification of methionine as the site of covalent attachment of a p-benzoyl-phenylalanine-containing analogue of substance P on the substance P (NK-1) receptor. J. Biol. Chem. 1996; 271: 25797–25800
   PubMed Web of Science ®Google Scholar
• Sklar L. A., Fay S. P., Seligmann B. E., Freer R. J., Muthukumaraswamy N., Mueller H. Fluorescence analysis of the size of a binding pocket of a peptide receptor at natural abundance. Biochemistry 1990; 29: 313–316
   PubMed Web of Science ®Google Scholar
• Muthukumaraswamy N., Freer R. J. Synthesis of chemotactic peptides. Methods Enzymol. 1988; 162: 132–139
   Google Scholar
• Allen R. A., Jesaitis A. J., Cochrane C. G. Photoaffinity labelling of N-formyl peptide receptors. Pharmac. Therap. 1987; 33: 333–348
   Google Scholar
• Ferrante A., Thong Y. H. Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method. J. Immun. Meth. 1980; 36: 109–117
   PubMed Web of Science ®Google Scholar
• Vosbeck K., Tobias P., Mueller H., Allen R. A., Arfors K. E., Ulevitch R. J., Sklar L. A. Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. J. Leuk. Bio. 1990; 47: 97–104
   Google Scholar
• Sklar L. A., Bokoch G. M., Button D., Smolen J. E. Regulation of ligand-receptor dynamics by guanine nucleotides. Real-time analysis of interconverting states for the neutrophil formyl peptide receptor. J. Biol. Chem. 1987; 262: 135–139
   PubMed Web of Science ®Google Scholar
• Hyslop P. A., Sklar L. A. A quantitative fluorimetric assay for the determination of oxidant production by polymorphonuclear leukocytes: its use in the simultaneous fluorimetric assay of cellular activation processes. Analy. Biochem. 1984; 141: 280–286
   PubMed Web of Science ®Google Scholar
• Prossnitz E. R., Schreiber R. E., Bokoch G. M., Ye R. D. Binding of low affinity N-formyl peptide receptors to G protein. Characterization of a novel inactive receptor intermediate. J. Biol. Chem. 1995; 270: 10686–10694
   PubMed Web of Science ®Google Scholar
• Fay S. P., Posner R. G., Swann W. N., Sklar L. A. Real-time analysis of the assembly of ligand, receptor, and G protein by quantitative fluorescence flow cytometry. Biochemistry 1991; 30: 5066–5075
   PubMed Web of Science ®Google Scholar
• Sklar L. A., Hyslop P. A., Oades Z. G., Omann G. M., Jesaitis A. J., Painter R. G., Cochrane C. G. Signal transduction and ligand-receptor dynamics in the human neutrophil. Transient responses and occupancy-response relations at the formyl peptide receptor. J. Biol. Chem. 1985; 260: 11461–11467
   PubMed Web of Science ®Google Scholar
• Sklar L. A., Oades Z. G., Jesaitis A. J., Painter R. G., Cochrane C. G. Fluoresceinated chemotactic peptide and high-affinity antifluorescein antibody as a probe of the temporal characteristics of neutrophil stimulation. Proc. Natl. Acad. Sci. USA 1981; 78: 7540–7544
   PubMed Web of Science ®Google Scholar
• Sklar L. A., Mueller H., Omann G., Oades Z. Three states for the formyl peptide receptor on intact cells. J. Biol. Chem. 1989; 264: 8483–8486
   PubMed Web of Science ®Google Scholar
• Posner R. G., Fay S. P., Domalewski M. D., Sklar L. A. Continuous spectrofluorometric analysis of formyl peptide receptor ternary complex interactions. Mol. Pharmacol. 1994; 45: 65–73
   Google Scholar
• Boulay F., Tardif M., Brouchon L., Vignais P. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 1990; 29: 11123–11133
   PubMed Web of Science ®Google Scholar
• Turcatti G., Vogel H., Chollet A. Probing the binding domain of the NK2 receptor with fluorescent ligands: evidence that heptapeptide agonists and antagonists bind differently. Biochemistry 1995; 34: 3972–3980
   Google Scholar
• Niedel J., Wilkinson S., Cuatrecasas P. Receptor-mediated uptake and degradation of 125I-chemotactic peptide by human neutrophils. J. Biol. Chem. 1979; 254: 10700–10706
   PubMedGoogle Scholar
• Schmitt M., Painter R. G., Jesaitis A. J., Preissner K., Sklar L. A., Cochrane C G. Photoaffinity labeling of the N-formyl peptide receptor binding site of intact human polymorphonuclear leukocytes. A label suitable for following the fate of the receptor-ligand complex. J. Biol. Chem. 1983; 258: 649–654
   Google Scholar
• Dorman G., Prestwich G. D. Benzophenone photophores in biochemistry. Biochemistry 1994; 33: 5661–5673
   PubMed Web of Science ®Google Scholar